Novel Potent and Selective Covalent Inhibitor of KRAS G12C

Potent, selective, and orally active antagonist for central adenosine A1 receptors

Novel Nonpeptide Bradykinin B2-Receptor Partial Agonist

Potent and nonadrenotoxic ACAT inhibitor

Nonprostanoid PGI2 agonist

Natural specific inhibitor of mammalian NSDHL and yeast Erg26p, inhibiting an artificial Hepatitis C viral replicon, and showung broad antifungal activity

Selective ET(A) receptor antagonist

Novel agonist of the formyl peptide receptor (FPR), protecting against myocardial ischaemia-reperfusion injury in mice

Novel NO-donating antimicrobial peptide, exhibiting Staphylococcus aureus and Escherichia coli biofilm dispersion and eradication, and potent antibacterial activities in vitro

Novel Photochromic Ion Channel Blocker

Novel Dipeptidyl Peptidase-4 (DPP-4) Inhibitor

Novel dipeptidyl peptidase IV (DPP4) inhibitor

Natural antibiotic, acting as an inhibitor of DOXP reductoisomerase

Impurity of Lenalidomide

Local anaesthetic agent, blocking voltage-gated Na(+) currents in neurons

Novel ALK PROTAC, being capable of degrading ALK in a folate receptor-dependent manner in cancer cells

Novel BRD PROTAC, being capable of degrading BRDs in a folate receptor-dependent manner in cancer cells

Inhibitor of IspD and IspE enzymes isolated from bacteria

Novel fluorescent near-infrared (NIR) linker for building brighter labeled biomolecules, exhibiting no evidence of H-aggregation even at high labeling density when appended to monoclonal antibodies or virus-like particles

First in class anti-tubercular agent against sensitive and drug-resistant Mycobacterium tuberculosis (Mtb)

Novel AMPK activator, inhibiting growth and induces apoptosis in colon cancer and increasing apoptosis in triple negative and estrogen-receptor positive breast cancers

Novel concentration-dependent inhibitor of CRF1R-pPL cotranslational translocation at the level of the Sec61 complex

Novel potent dual CDK14 and CDK16 inhibitor

Novel potent and selective Dual inhibitor of PI3K-δ and PI3K-γ

Novel highly selective inhibitor of Aurora kinases A, B and C, with potent cellular activity and minimal off-target activity (PLK4)

Negative control for Skepinone-L

Negative control for FM-381

Fluorescent probe for monitoring synaptic activity at neuromuscular junctions

alpha2-Adrenergic receptor agonist

Benzodiazepine with sedative, muscle relaxant, anticonvulsant, and anxiolytic activities